XBiotech (XBIT) Deferred Taxes (2015 - 2019)
XBiotech (XBIT) posted Deferred Taxes of -$3000.0 for Q1 2019, up 25.0% on a QoQ basis from -$4000.0 in Q4 2018, and little changed year-over-year from -$3000.0 in Q1 2018.
Analysis
XBiotech (XBIT) Deferred Taxes (2015 - 2019) Analysis & Trends
XBiotech has reported Deferred Taxes for 5 years, with the latest figure at -$3000.0 in Q1 2019.
- On a quarterly basis, Deferred Taxes changed 0.0% year-over-year to -$3000.0 in Q1 2019; TTM through Dec 2019 was -$3000.0, a 80.0% increase from a year earlier, with the FY2019 full-year figure at -$3000.0, up 80.0% from the prior year.
- Deferred Taxes was -$3000.0 for Q1 2019 at XBiotech, up from -$4000.0 in the prior quarter.
- The five-year high for Deferred Taxes was $5000.0 in Q2 2015, with the low at -$4000.0 in Q2 2018.
- Average Deferred Taxes over 5 years is $200.0, with a median of $1000.0 recorded in 2016.
- The sharpest annual moves came in 2016 and 2017: Deferred Taxes soared 100.0% in 2016, then plunged 300.0% in 2017.
- Over 5 years, Deferred Taxes stood at $5000.0 in 2015, then tumbled by 80.0% to $1000.0 in 2016, then slumped by 300.0% to -$2000.0 in 2017, then sank by 100.0% to -$4000.0 in 2018, then increased by 25.0% to -$3000.0 in 2019.
- The last three Deferred Taxes figures came in at -$3000.0 (Q1 2019), -$4000.0 (Q4 2018), and -$4000.0 (Q3 2018), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | -291.00 Mn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | -587.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | -69.70 Mn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 194.40 Mn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 2.66 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | -27.60 Mn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | XBiotech | 66.16 Mn | 66.16 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2019 | -3,000.00 |
| Dec 31, 2018 | -4,000.00 |
| Sep 30, 2018 | -4,000.00 |
| Jun 30, 2018 | -4,000.00 |
| Mar 31, 2018 | -3,000.00 |
| Dec 31, 2017 | -2,000.00 |
| Sep 30, 2017 | -1,000.00 |
| Dec 31, 2016 | 1,000.00 |
| Sep 30, 2016 | 1,000.00 |
| Jun 30, 2016 | 1,000.00 |
| Mar 31, 2016 | 4,000.00 |
| Dec 31, 2015 | 5,000.00 |
| Sep 30, 2015 | 5,000.00 |
| Jun 30, 2015 | 5,000.00 |
| Mar 31, 2015 | 2,000.00 |